遏制乳腺癌：使癌症干细胞和肿瘤微环境戛然而止的治疗机遇。 - Suppr

Suppr

超能文献

Putting the brakes on breast cancer: therapeutic opportunities to bring cancer stem cells and the tumor microenvironment to a screeching halt.

作者信息

Vargo-Gogola T

出版信息

Curr Drug Targets. 2010 Sep;11(9):1041-2. doi: 10.2174/138945010792006834.

DOI:10.2174/138945010792006834

PMID:20545615

Abstract

摘要

相似文献

Putting the brakes on breast cancer: therapeutic opportunities to bring cancer stem cells and the tumor microenvironment to a screeching halt.

Curr Drug Targets. 2010 Sep;11(9):1041-2. doi: 10.2174/138945010792006834.

Targeting the perpetrator: breast cancer stem cell therapeutics.

Curr Drug Targets. 2010 Sep;11(9):1147-56. doi: 10.2174/138945010792006843.

Tumor-infiltrating macrophages, cancer stem cells and therapeutic responses.

Oncotarget. 2012 Dec;3(12):1497-8. doi: 10.18632/oncotarget.792.

The impact of tumor stroma on drug response in breast cancer.

Semin Cancer Biol. 2015 Apr;31:3-15. doi: 10.1016/j.semcancer.2014.05.006. Epub 2014 Jun 6.

Hierarchy of breast cancer cells: key to reverse dormancy for therapeutic intervention.

Stem Cells Transl Med. 2014 Jul;3(7):782-6. doi: 10.5966/sctm.2014-0013. Epub 2014 May 15.

Metastatic niche functions and therapeutic opportunities.

Nat Cell Biol. 2018 Aug;20(8):868-877. doi: 10.1038/s41556-018-0145-9. Epub 2018 Jul 26.

Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.

Clin Sci (Lond). 2015 Dec;129(12):1037-45. doi: 10.1042/CS20150451.

Emerging targeted agents in metastatic breast cancer.

Nat Rev Clin Oncol. 2013 Apr;10(4):191-210. doi: 10.1038/nrclinonc.2013.29. Epub 2013 Mar 5.

What are the clinical implications of breast-cancer stem cells?

Lancet Oncol. 2008 Jun;9(6):514. doi: 10.1016/s1470-2045(08)70141-4.

Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.

Transl Res. 2015 May;165(5):558-77. doi: 10.1016/j.trsl.2014.10.011. Epub 2014 Nov 1.

引用本文的文献

Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133 cells in clear cell renal carcinoma.

FASEB Bioadv. 2020 Jan 3;2(2):126-144. doi: 10.1096/fba.2019-00071. eCollection 2020 Feb.

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Cancer Metastasis Rev. 2016 Dec;35(4):547-573. doi: 10.1007/s10555-016-9653-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Putting the brakes on breast cancer: therapeutic opportunities to bring cancer stem cells and the tumor microenvironment to a screeching halt.

Curr Drug Targets. 2010 Sep;11(9):1041-2. doi: 10.2174/138945010792006834.

Targeting the perpetrator: breast cancer stem cell therapeutics.

Curr Drug Targets. 2010 Sep;11(9):1147-56. doi: 10.2174/138945010792006843.

Tumor-infiltrating macrophages, cancer stem cells and therapeutic responses.

Oncotarget. 2012 Dec;3(12):1497-8. doi: 10.18632/oncotarget.792.

The impact of tumor stroma on drug response in breast cancer.

Semin Cancer Biol. 2015 Apr;31:3-15. doi: 10.1016/j.semcancer.2014.05.006. Epub 2014 Jun 6.

Hierarchy of breast cancer cells: key to reverse dormancy for therapeutic intervention.

Stem Cells Transl Med. 2014 Jul;3(7):782-6. doi: 10.5966/sctm.2014-0013. Epub 2014 May 15.

Metastatic niche functions and therapeutic opportunities.

Nat Cell Biol. 2018 Aug;20(8):868-877. doi: 10.1038/s41556-018-0145-9. Epub 2018 Jul 26.

Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.

Clin Sci (Lond). 2015 Dec;129(12):1037-45. doi: 10.1042/CS20150451.

Emerging targeted agents in metastatic breast cancer.

Nat Rev Clin Oncol. 2013 Apr;10(4):191-210. doi: 10.1038/nrclinonc.2013.29. Epub 2013 Mar 5.

What are the clinical implications of breast-cancer stem cells?

Lancet Oncol. 2008 Jun;9(6):514. doi: 10.1016/s1470-2045(08)70141-4.

Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.

Transl Res. 2015 May;165(5):558-77. doi: 10.1016/j.trsl.2014.10.011. Epub 2014 Nov 1.

引用本文的文献

Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133 cells in clear cell renal carcinoma.

FASEB Bioadv. 2020 Jan 3;2(2):126-144. doi: 10.1096/fba.2019-00071. eCollection 2020 Feb.

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Cancer Metastasis Rev. 2016 Dec;35(4):547-573. doi: 10.1007/s10555-016-9653-x.